<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05028517</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00006555</org_study_id>
    <secondary_id>U01AA026104</secondary_id>
    <nct_id>NCT05028517</nct_id>
  </id_info>
  <brief_title>Efficacy Trial of the FMF Connect Mobile Health Intervention</brief_title>
  <official_title>Efficacy Trial of the FMF Connect Mobile Health Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test a new smartphone &quot;app&quot; for parents/caregivers of&#xD;
      children with fetal alcohol spectrum disorder (FASD). The app is called Families Moving&#xD;
      Forward (FMF) Connect. The goal of the app is to provide parents/caregivers with useful&#xD;
      information to help manage their children's condition and obtain peer support.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2021</start_date>
  <completion_date type="Anticipated">May 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study involves a three arm randomized controlled trial with equal allocation to the following conditions: (1) FMF Connect + coaching, (2) FMF Connect alone, and (3) waitlist control. Quantitative survey data will be collected at three timepoints: baseline (T1), 6-weeks (T2), and 12-weeks (T3).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Effect size in Eyberg Child Behavior Inventory</measure>
    <time_frame>baseline to 12 weeks</time_frame>
    <description>The Eyberg Child Behavior Inventory measures the intensity of child behavior problems, scores have a mean of 50 and a standard deviation of 10 with higher scores indicating worse outcomes. An effect size of 0.2 is small, 0.5 is medium and 0.8 is large.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean effect size in Reasons for Children's Behavior measure</measure>
    <time_frame>baseline to 12 weeks</time_frame>
    <description>The Reasons for Children's Behavior measure assesses parents attributions of behavior and ranges from 30 to 180 with higher scores reflecting greater agreement with neurodevelopmental attributions. An effect size of 0.2 is small, 0.5 is medium and 0.8 is large.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean effect size in Parenting Sense of Competence scale for efficacy</measure>
    <time_frame>baseline to 12 weeks</time_frame>
    <description>The Parenting sense of competence scale measures how effective parents feel they are and ranges from 7 to 42 with higher scores indicating worse outcomes. An effect size of 0.2 is small, 0.5 is medium and 0.8 is large.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean effect size in Parenting Sense of Competence scale for satisfaction</measure>
    <time_frame>baseline to 12 weeks</time_frame>
    <description>The Parenting sense of competence scale measures satisfaction with parenting and ranges from 9 to 54 with higher scores indicating better outcomes. An effect size of 0.2 is small, 0.5 is medium and 0.8 is large.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean effect size in Family Needs Questionnaire</measure>
    <time_frame>baseline to 12 weeks</time_frame>
    <description>The family needs questionnaire measures the degree to which family needs are met and ranges from 0-4 with 4 indicating more needs are met. An effect size of 0.2 is small, 0.5 is medium and 0.8 is large.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean effect size in FASD knowledge</measure>
    <time_frame>baseline to 12 weeks</time_frame>
    <description>The Knowledge and Advocacy questionnaire assesses caregiver knowledge about FASD and advocacy and ranges from 0 to 30. Higher scores reflect greater knowledge. An effect size of 0.2 is small, 0.5 is medium and 0.8 is large.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean effect size in self-care confidence</measure>
    <time_frame>baseline to 12 weeks</time_frame>
    <description>The self-care confidence scale ranges from 1-5 with 5 indicating greater confidence in self-care. An effect size of 0.2 is small, 0.5 is medium and 0.8 is large.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Mobile app rating tool</measure>
    <time_frame>12 weeks</time_frame>
    <description>The mobile app tool measures users perception of app quality and ranges from 4-20 with higher scores reflecting greater perceived quality of the app.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Fetal Alcohol Spectrum Disorders</condition>
  <arm_group>
    <arm_group_label>FMF Connect Intervention + Coaching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive the FMF Connect mobile health app plus text-based coaching to support continued use of the app and individualized goal setting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FMF Connect Intervention (no coaching)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants receive the FMF Connect mobile health app. They do not receive coaching.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist comparison group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants receive the FMF Connect mobile health app at the conclusion of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FMF Connect</intervention_name>
    <description>The FMF Connect intervention includes cloud infrastructure and an innovative, multilayered mobile app. It incorporates tailored content for parents/caregivers of children (ages 3-12) with FASD or PAE. The app integrates five main components: 1) Dashboard; 2) Learning Modules; 3) Family Forum; 4) Library; and 5) Notebook. Weekly emails are also sent to support motivational engagement.</description>
    <arm_group_label>FMF Connect Intervention (no coaching)</arm_group_label>
    <arm_group_label>FMF Connect Intervention + Coaching</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Coaching</intervention_name>
    <description>A text-based coaching module is added to the FMF Connect app. Coaches support continued use of the app and individualized goal setting.</description>
    <arm_group_label>FMF Connect Intervention + Coaching</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Biological parent or other primary caregiver (e.g., foster or adoptive parent,&#xD;
             relative, legal guardian) of a child with FASD or prenatal alcohol exposure (PAE)&#xD;
&#xD;
          -  The parent/caregiver must be at least 18 years old&#xD;
&#xD;
          -  The child must between the ages of 3 and 12 years old&#xD;
&#xD;
          -  The child has a diagnosis of FASD or has confirmed PAE&#xD;
&#xD;
          -  The child has lived with the parent/caregiver for at least 4 months and is expected to&#xD;
             remain in the home for at least 1 year&#xD;
&#xD;
          -  The parent/caregiver lives in the United States&#xD;
&#xD;
          -  The parent/caregiver has a smartphone or ipad with iOS operating system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The parent/caregiver is not fluent in English (the FMF Connect app and pre-post&#xD;
             measures are currently only available in English)&#xD;
&#xD;
          -  There is another parent/caregiver of the same child or living in the home that is&#xD;
             already enrolled in the study (couples are excluded to prevent dependence in the data)&#xD;
&#xD;
          -  The family has previously received or is currently receiving the therapist-led&#xD;
             Families Moving Forward (FMF) Program&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christie Petrenko, PhD</last_name>
    <phone>585-275-2991</phone>
    <email>christie_petrenko@urmc.rochester.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Christie Petrenko, PhD</last_name>
      <phone>585-275-2991</phone>
      <email>christie_petrenko@urmc.rochester.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 24, 2021</study_first_submitted>
  <study_first_submitted_qc>August 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Christie Petrenko</investigator_full_name>
    <investigator_title>Research Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Alcohol Spectrum Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data is deposited quarterly into the Collaborative Initiative on Fetal Alcohol Spectrum Disorders central repository.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>It will be available once the data is collected and will be available indefinitely.</ipd_time_frame>
    <ipd_url>http://www.cifasd.org/data-sharing</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

